LPL Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.8M | Buy |
|
|||||
|
2025
Q2 | $3.73M | Buy |
|
|||||
|
2025
Q1 | $1.8M | Sell |
|
|||||
|
2024
Q4 | $2.29M | Buy |
|
|||||
|
2024
Q3 | $1.51M | Buy |
|
|||||
|
2024
Q2 | $1.7M | Sell |
|
|||||
|
2024
Q1 | $1.73M | Buy |
|
|||||
|
2023
Q4 | $1.29M | Buy |
|
|||||
|
2023
Q3 | $1.1M | Buy |
|
|||||
|
2023
Q2 | $775K | Buy |
|
|||||
|
2023
Q1 | $829K | Sell |
|
|||||
|
2022
Q4 | $1.34M | Sell |
|
|||||
|
2022
Q3 | $1.65M | Sell |
|
|||||
|
2022
Q2 | $1.65M | Sell |
|
|||||
|
2022
Q1 | $1.7M | Sell |
|
|||||
|
2021
Q4 | $1.65M | Sell |
|
|||||
|
2021
Q3 | $2M | Buy |
|
|||||
|
2021
Q2 | $1.38M | Buy |
|
|||||
|
2021
Q1 | $633K | Sell |
|
|||||
|
2020
Q4 | $819K | Buy |
|
|||||
|
2020
Q3 | $755K | Buy |
|
|||||
|
2020
Q2 | $754K | Buy |
|
|||||
|
2020
Q1 | $502K | Sell |
|
|||||
|
2019
Q4 | $645K | Buy |
|
|||||
|
2019
Q3 | $305K | Sell |
|
|||||
|
2019
Q2 | $304K | Sell |
|
|||||
|
2019
Q1 | $401K | Buy |
|
|||||
|
2018
Q4 | $278K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $202K | Buy |
|